Results 161 to 170 of about 38,424 (214)
Exercise adherence, perceived exercise benefits and barriers, and spinal mobility in ankylosing spondylitis: a cross-sectional study. [PDF]
Rheumatol IntUsen A, Kuculmez O, Yavuz MO.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Lancet, The, 2007
Ankylosing spondylitis is a common inflammatory rheumatic disease that affects the axial skeleton, causing characteristic inflammatory back pain, which can lead to structural and functional impairments and a decrease in quality of life. New imaging techniques and therapies have substantially changed the management of this disease in the past decade ...
Jürgen Braun, Joachim Sieper
exaly +5 more sources
Ankylosing spondylitis is a common inflammatory rheumatic disease that affects the axial skeleton, causing characteristic inflammatory back pain, which can lead to structural and functional impairments and a decrease in quality of life. New imaging techniques and therapies have substantially changed the management of this disease in the past decade ...
Jürgen Braun, Joachim Sieper
exaly +5 more sources
JAMA: The Journal of the American Medical Association, 1977
Ankylosing spondylitis occurs chiefly in young men and affects principally the sacroiliac, apophyseal, and costovertebral joints. Physical findings may be minimal, and special tests may be necessary to find objective evidence of the disease. HLA-B27 histocompatibility antigen is present in 90% to 95% of patients.
openaire +4 more sources
Ankylosing spondylitis occurs chiefly in young men and affects principally the sacroiliac, apophyseal, and costovertebral joints. Physical findings may be minimal, and special tests may be necessary to find objective evidence of the disease. HLA-B27 histocompatibility antigen is present in 90% to 95% of patients.
openaire +4 more sources
Nursing Standard, 2006
This article provides an overview of ankylosing spondylitis, a chronic condition characterised by abnormal ossification and ankylosis affecting the spine and sacro-iliac joints. It explores the needs of patients with the condition and identifies pharmacological and non-pharmacological approaches to disease management.
openaire +2 more sources
This article provides an overview of ankylosing spondylitis, a chronic condition characterised by abnormal ossification and ankylosis affecting the spine and sacro-iliac joints. It explores the needs of patients with the condition and identifies pharmacological and non-pharmacological approaches to disease management.
openaire +2 more sources
Baillière's Clinical Rheumatology, 1993
Ankylosing spondylitis is an inflammatory disease involving entheses and joints, especially those in and around the spine. The most widespread involvement of the respiratory system by this disease occurs when this pathological process gives rise to chest wall pain, diminished chest wall movement and a dorsal stoop.
openaire +2 more sources
Ankylosing spondylitis is an inflammatory disease involving entheses and joints, especially those in and around the spine. The most widespread involvement of the respiratory system by this disease occurs when this pathological process gives rise to chest wall pain, diminished chest wall movement and a dorsal stoop.
openaire +2 more sources
Disability in ankylosing spondylitis
Disability and Rehabilitation, 1999This study was designed to examine the functional loss in ankylosing spondylitis and explore the relationship between disability and various factors such as age, disease duration, disease activity, spinal mobility, chest expansion, peripheral joint involvement, radiological changes, and psychosocial well-being.Forty-two patients were included in this ...
M, Dalyan +4 more
openaire +2 more sources
Osteoporosis in Ankylosing Spondylitis
Current Rheumatology Reports, 2010Osteoporosis (OP) is a frequent complication of ankylosing spondylitis (AS), even in early stages of the disease, and is associated with elevated levels of biochemical markers of bone turnover, proinflammatory cytokines, and acute-phase reactants. This suggests that systemic inflammatory mediators, such as interleukin-6 and tumor necrosis factor-alpha,
Marina, Magrey, Muhammad Asim, Khan
openaire +2 more sources